[en] Background: C-reactive protein (CRP) is a well-known acute-phase protein in dogs
that may discriminate bacterial bronchopneumonia from other pulmonary conditions.
Bronchopneumonia caused by Bordetella bronchiseptica (Bb) is common but the associated
increase in CRP concentration in naturally infected dogs has not been fully explored.
Objective: To compare CRP concentrations of dogs with Bb infection, with or without
radiographic pulmonary lesions, to dogs with aspiration bronchopneumonia (ABP).
Disciplines :
Veterinary medicine & animal health Veterinary medicine & animal health
Menard, Maud; Ecole nationale vétérinaire d’Alfort, Univ Paris Est Créteil, Maisons-Alfort, France > Department of Medicine
Maurey, Christelle; Ecole nationale vétérinaire d’Alfort, Univ Paris Est Créteil, Maisons-Alfort, France > Department of Medicine
Benchrekroun, Ghita; Ecole nationale vétérinaire d’Alfort, Univ Paris Est Créteil, Maisons-Alfort, France > Department of Medicine
Fernandes Rodrigues, Nina ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Billen, Frédéric ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Clercx, Cécile ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Language :
English
Title :
Comparison of C-reactive protein concentrations in dogs with Bordetella bronchiseptica infection and aspiration bronchopneumonia
Radhakrishnan A, Drobatz KJ, Culp WT, King KG. Community-acquired infectious pneumonia in puppies: 65 cases (1993-2002). J Am Vet Med Assoc. 2007;230(10):1493-1497.
Priestnall SL, Mitchell JA, Walker CA, Erles K, Brownlie J. New and emerging pathogens in canine infectious respiratory disease. Vet Pathol. 2014;51(2):492-504.
Schulz BS, Kurz S, Weber K. Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections. Vet J. 2014;201(3):365-369.
Canonne AM, Billen F, Tual C, et al. Quantitative PCR and cytology of bronchoalveolar lavage fluid in dogs with Bordetella bronchiseptica infection. J Vet Intern Med. 2016;30(4):1204-1209.
Decaro N, Mari V, Larocca V, et al. Molecular surveillance of traditional and emerging pathogens associated with canine infectious respiratory disease. Vet Microbiol. 2016;30(192):21-25.
Joffe DJ, Lelewski R, Weese J, et al. Factors associated with development of canine infectious respiratory disease complex (CIRDC) in dogs in 5 Canadian small animal clinics. Can Vet J. 2016;57(1):46-51.
Taha-Abdelaziz K, Bassel LL, Harness ML, Clark ME, Register KB, Caswell JL. Cilia-associated bacteria in fatal Bordetella bronchiseptica pneumonia of dogs and cats. J Vet Diagn Invest. 2016;28(4):369-376.
Canonne AM, Roels E, Menard M, Desquilbet L, Billen F, Clercx C. Clinical response to two protocols of aerosolized gentamicin and impact of factors on outcome in 46 dogs with Bordetella bronchiseptica infection (2012–2018). J Vet Intern Med. 2020;34:2078-2085.
Ceron JJ, Eckersall PD, Martýnez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Vet Clin Pathol. 2005;34(2):85-99.
Stockham SL. In: Stockham SL, Scott MA, eds. Fundamentals of Veterinary Clinical Pathology. 2nd ed. St Louis, MO: Wiley-Blackwell; 2008:370-413.
Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J. 2010;185(1):23-27.
Caspi D, Snel FW, Batt RM, et al. C-reactive protein in dogs. Am J Vet Res. 1987;48(6):919-921.
Yamashita K, Fujinaga T, Miyamoto T, Hagio M, Izumisawa Y, Kotani T. Canine acute phase response: relationship between serum cytokine activity and acute phase protein in dogs. J Vet Med Sci. 1994;56(3):487-492.
Hillström A, Hagman R, Tvedten H, Kjelgaard-Hansen M. Validation of a commercially available automated canine-specific immunoturbidimetric method for measuring canine C-reactive protein. Vet Clin Pathol. 2014;43:235-243.
Klenner S, Bauer N, Moritz A. Evaluation of three automated human immunoturbidimetric assays for the detection of C-reactive protein in dogs. J Vet Diagn Invest. 2010;22:544-552.
Gebhardt C, Hirschberger J, Rau S, et al. Use of C-reactive protein to predict outcome in dogs with systemic inflammatory response syndrome or sepsis. J Vet Emerg Crit Care. 2009;19(5):450-458.
Lowrie M, Penderis J, Eckersall PD, McLaughlin M, Mello D, Anderson TJ. The role of acute phase proteins in diagnosis and management of steroid-responsive meningitis arteritis in dogs. Vet J. 2009;182(1):125-130.
Mitchell KD, Kruth SA, Wood RD, Jefferson B. Serum acute phase protein concentrations in dogs with autoimmune hemolytic anemia. J Vet Intern Med. 2009;23(3):585-591.
Baric Rafaj R, Kuleš J, Selanec J, et al. Markers of coagulation activation, endothelial stimulation, and inflammation in dogs with babesiosis. J Vet Intern Med. 2013;27(5):1172-1178.
McClure V, van Schoor M, Thompson PN, Kjelgaard-Hansen M, Goddard A. Evaluation of the use of serum C-reactive protein concentration to predict outcome in puppies infected with canine parvovirus. J Am Vet Med Assoc. 2013;243(3):361-366.
Foster JD, Sample S, Kohler R, Watson K, Muir P, Trepanier LA. Serum biomarkers of clinical and cytologic response in dogs with idiopathic immune-mediated polyarthropathy. J Vet Intern Med. 2014;28(3):905-911.
Martinez-Subiela S, Pardo-Marín L, Tecles F, Baneth G, Cerón JJ. Serum C-reactive protein and ferritin concentrations in dogs undergoing leishmaniosis treatment. Res Vet Sci. 2016;109:17-20.
Cantos-Barreda A, Escribano D, Cerón JJ, et al. Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis. Vet Parasitol 2018;260:63-68.
Ceron JJ, Pardo-Marin L, Caldin M, et al. Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: general recommendations. BMC Vet Res. 2018;14(1):196.
Kim H, Kim HJ, Kang JH, Kang BT, Yang MP. Evaluation of serum C-reactive protein and high mobility group box 1 concentrations in 22 dogs with acute pancreatitis: a pilot study. Vet Q. 2019 Dec;39(1):122-130.
Viitanen SJ, Laurila HP, Lilja-Maula LI, Melamies MA, Rantala M, Rajamäki MM. Serum C-reactive protein as a diagnostic biomarker in dogs with bacterial respiratory diseases. J Vet Intern Med. 2014;28(1):84-91.
Viitanen SJ, Lappalainen AK, Christensen MB, Sankari S, Rajamäki MM. The utility of acute-phase proteins in the assessment of treatment response in dogs with bacterial pneumonia. J Vet Intern Med. 2017;31(1):124-133.
Yamamoto S, Shida T, Honda M, et al. Serum C-reactive protein and immune responses in dogs inoculated with Bordetella bronchiseptica (phase I cells). Vet Res Commun. 1994;18(5):347-357.
EUROlyser Solo, validated in 2015 [Evaluation of three different point-of-care tests for quantitative measurement of canine C-reactive protein, Jasensky A-K, Klenner S, Einspanier R, Kohn B. Vet Clin Pathol 2015;44(2):205-214.]
Kutz A, Grolimund E, Christ-Crain M, et al. Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients. BMC Anesthesiol. 2014;14:102.
Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest. 2011;139:1410-1418.
Wu X, Qiang C, Kai-Hu Y, et al. Pertussis detection in children with cough of any duration. BMC Pediatr. 2019;19:236.
Dos Anjos BL, Grotto HZ. Evaluation of C-reactive protein and serum amyloid A in the detection of inflammatory and infectious diseases in children. Clin Chem Lab Med. 2010;48(4):493-499.
Christensen MB, Langhorn R, Goddard A, et al. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs. Can Vet J. 2014;55(2):161-168.
Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections-full version. Clin Microbiol Infect. 2011;17(Suppl 6):E1-E59.
Salluh JF, Souza-Dantas VC, Póvoa P. The current status of biomarkers for the diagnosis of nosocomial pneumonias. Curr Opin Crit Care. 2017;23(5):391-397.
Salluh JF, Souza-Dantas VC, Póvoa P. Place of biomarkers in the management of pulmonary infections. Rev Mal Respir. 2019;36(3):405-414.
Htun TP, Sun Y, Chua HL, Pang J. Clinical features for diagnosis of pneumonia among adults in primary care setting: a systematic and meta-review. Sci Rep. 2019;9(1):7600.
Ebell MH, Bentivegna M, Cai X, Hulme C, Kearney M. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis. Acad Emerg Med. 2020 Mar;27(3):195-206.
Karakioulaki M, Stolz D. Biomarkers and clinical scoring systems in community-acquired pneumonia. Ann Thorac Med. 2019;14(3):165-172.
Goggs R, Milloway M, Troia R, Giunti M. Plasma procalcitonin concentrations are increased in dogs with sepsis. Vet Rec Open. 2018;5:e000255.
